When SRX gets full Nasdaq listing in USA there will be shares open to 25 million US investors. Biotechs in USA that have growth rates of 75-100% trade at PE ratios of at least 35-40. AT a P.E of 35xeps of 35 cents this year this is sp of $12.25. A PE of 35x next years eps estimate of $69 cents = $24.15 a share. At present sp of $4.20 this is the most undervalued biotech I have ever seen and gap will be filled shortly with new highs. See my earlier prediction. This is my opinion only and do your own work as I have . I have been in industry over 30 yrs.
When SRX gets full Nasdaq listing in USA there will be shares...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 6800 | 2 |
View Market Depth
| Last trade - 09.15am 30/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |
Day chart unavailable